Madrigal Pharmaceuticals Engages with Investors at Key Conferences

Madrigal Pharmaceuticals

CONSHOHOCKEN, PAMadrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) has announced its participation in several prominent investor conferences, marking an important opportunity to engage with the financial community and highlight the company’s strategic initiatives. The company will participate in fireside chats, which are set to be webcast live.

The schedule kicks off with the UBS Global Healthcare Conference on November 13, 2024, at 2:00 P.M. EST. This event provides a platform for Madrigal to discuss its latest advancements and future plans with a broad audience of investors and analysts.

Following this, Madrigal will present at the 7th Annual Evercore HealthCONx Conference on December 4, 2024, at 9:35 A.M. EST. The conference is a key venue for healthcare companies to connect with investors and share insights on industry trends.

The series concludes at the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024, at 8:30 A.M. EST, another significant event in the healthcare investment calendar.

Interested parties can access the live webcasts through Madrigal’s Investor Relations Events page, ensuring broad access to the company’s presentations.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  FDA Grants Breakthrough Therapy Designation to Johnson & Johnson's Nipocalimab for Sjögren's Disease